Actively Recruiting
Real-Time AI-Assisted Confocal Microscopy for Improved Surgical Removal of Basal Cell Carcinoma
Led by LMU Klinikum · Updated on 2026-08-26
1000
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of artificial intelligence AI to assist surgeons in analyzing confocal laser scanning microscopy CLSM tissue images during surgeries for basal cell carcinoma BCC. The goal is to integrate AI analysis in real time to help distinguish between tumor tissue, inflammatory tissue, and non-tumor or non-inflammatory tissue. This method aims to provide more precise and faster tissue analysis to potentially improve surgical outcomes and support healthcare professionals. The study involves the use of ex vivo confocal microscopy images from BCC surgeries, which AI will analyze to provide real-time feedback to surgeons during the operation. This approach focuses on automated image analysis to facilitate a more targeted surgical excision of basal cell carcinoma tissue. Participants will undergo tissue imaging using CLSM during surgery, and the AI system will analyze these images to assist in identifying tissue types. The primary outcome is the evaluation of ex vivo confocal laser scanning microscopy over a two-year period. The study will monitor how well AI can support surgical decision-making and tissue analysis throughout the trial duration, which is expected to complete by the end of 2027.
CONDITIONS
Brief Title
Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma
Research Team
M
Maximilian Deußing, Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here